¼ÐÃD: ¤éªÑ¤À¨É
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 15:28  ¸ê®Æ ¨p¤H°T®§ 
³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 15:30  ¸ê®Æ ¨p¤H°T®§ 
NOF CORPORATION (¤éªÑ 4403) (¤Æ¾Ç)


https://www.nof.co.jp/english/business/oleo/index.html


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 15:32  ¸ê®Æ ¨p¤H°T®§ 
Kansai Paint 関¦èÇÖÇ~ÇïÇĮ覡会ªÀ (¤éªÑ 4613) (¤Æ¾Ç,ªoº£)

https://www.kansai.com/products/index.html

https://en.wikipedia.org/wiki/Kansai_Paint


Kansai Paint Co.,Ltd. (関¦èÇÖÇ~ÇïÇĮ覡会ªÀ Kansai Peinto Kabushiki-gaisha) is a Japanese, Osaka-based chemical company whose main products are automotive, industrial and decorative coatings.[2] The company uses ALESCO as its corporate brand which it introduced in June 1987.


The company is one of the world's top ten paint manufacturers with manufacturing sites in over 43 countries across the world.[3]


Kansai Paint is a member of the Mitsubishi UFJ Financial Group (MUFJ) keiretsu.



Kansai Paint Co.,Ltd.

Native name
Type
Traded asIndustryFoundedHeadquartersKey people
ProductsServicesRevenueNet income
Number of employees
SubsidiariesWebsite
The company headquarters building in Osaka
関¦èÇÖÇ~ÇïÇĮ覡会ªÀ
Public KK
TYO: 4613
Chemicals
Amagasaki (May 17, 1918; 100 years ago)
6-14, Imabashi 2-chome, Chuo-ku, Osaka 541-8523, Japan
Hirosi Isino
(President)

Control and undertaking of painting works
US$ 3.11 billion (FY 2013)
(JPY 320.45 billion) (FY 2013)
US$ 209.48 million (FY 2013)
(JPY 21.56 billion) (FY 2013)
11,917 (consolidated, as of March 31, 2014)
Kansai Nerolac Paints
Official website
Footnotes / references
[1][2]


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 15:38  ¸ê®Æ ¨p¤H°T®§ 
DIC Corporation (¤éªÑ 4631) (¤Æ¾Ç)
  
http://www.dic-global.com/en/business/

http://www.dic-global.com/en/about/


Color & Comfort¡X DIC is a fine chemicals company with a top share in printing inks, organic pigments and PPS compounds in the global market. Established in 1908 as a manufacturer of printing inks, DIC has capitalized on its capabilities in organic pigments and synthetic resins to build a broad portfolio to markets such as automobiles, electronics, foods and housing. DIC operates in more than 60 countries and territories around the world today.



https://en.wikipedia.org/wiki/DIC_Corporation



DIC Corporation (DIC®è¦¡会ªÀ Dī Ai Shī Kabushiki-gaisha) is Japanese chemical company, specializing in the development, manufacture and sale of inks, pigments, polymers, specialty plastics and compounds and biochemicals.[4]

It was founded in 1908 as Kawamura Ink Manufactory, renamed to Kawamura Kijuro Shoten in 1915, incorporated as Dainippon Printing Ink Manufacturing in 1937 and renamed to Dainippon Ink and Chemicals (DIC) in 1962 before the name was changed to the present name DIC Corporation in 2008 on the occasion of its 100th anniversary.[5] The company slogan "Color & Comfort By Chemistry" suggests that DIC products should deliver color and comfort to daily life.

The company operates worldwide (through 176 subsidiary and affiliate companies in 62 countries) and includes the Sun Chemical corporation, based in the Americas and Europe.[1]
DIC in Japan has 10 plants in Japan, located in Tokyo, Chiba, Hokuriku, Sakai, Kashima, Yokkaichi, Shiga, Komaki, Saitama, and Tatebayashi. The main research laboratory in Japan is located in Sakura, Chiba cooperating with DIC development centers in China (Qingdao DIC Finechemicals Co., Ltd., Qingdao, China) and the Sun Chemical Group's research laboratories (in USA, Germany and UK).[6]

The company is listed on the Tokyo Stock Exchange.

DIC Corporation
DIC®è¦¡会ªÀ


Type
Traded asIndustryFoundedFounderHeadquartersKey people
ProductsRevenueNet income
Number of employees
Website
Company logo used since 2008
Public KK
TYO: 4631
Chemicals
Tokyo, Japan February 1908
Kijuro Kawamura
Waterras Tower, 101, Kanda Awajicho 2-chome, Chiyoda-ku, Tokyo 101-0063, Japan


$ 7.487 billion USD (FY 2012)
(¥ 703.8 billion JPY) (FY 2012)
$ 202.809 million USD (FY2012)
(¥ 19.1 billion JPY) (FY 2012)
20,034 (consolidated) (as of December 31, 2013)
Official website
Footnotes / references
[1][2][3]


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 15:43  ¸ê®Æ ¨p¤H°T®§ 
Lion Corporation ·à¤ý®è¦¡·|ªÀ (¤éªÑ 4912) (¥Á¥Í®ø¶O¥Î«~ , ¤Æ¾Ç)




https://www.lion.co.jp/ch/t/company/about/

https://zh.wikipedia.org/wiki/%E7%8D%85%E7%8E%8B



·à¤ý¡]¤é»y¡GÇåÇ~ǦÇï¡ALION¡^¬O¤é¥»¤@®a¤é¥Î«~»s³y°Ó¡A¥D­n¥Í²£¬~¾¯¡BªÎ¨m¡B¤ú»Iµ¥¤é¥Î«~¡A¥H¤ÎÂåÃÄ«~¡B¤Æ¤u²£«~¡AÁ`³¡¦ì©óªF¨Ê¥»©Ò¡C¤½¥q¥Ñ¤pªL´I¦¸­¦¦b1891¦~¡]©úªv24¦~¡^10¤ë³Ð«Ø¡A·í®É¥H³c»s¡u·à¼ÐLION¾¦¿i¡v¡]¤é»y¡G·à¤l¦LÇåÇ~ǦÇï歯¿i¡^¼ä¾¦¯»µo¸ñ¡A1896¦~²Ä¤@´Ú·à¤ý¤ú¯»¤W¥«¡A±µµÛ¦b1911¦~¤é¥»²Ä¤@¤ä¤ú»I¢w¢w·à¤ý¤ú»I¤W¥«¡A¸Ó¤½¥q¦b·í®É¦³µÛ«Ü°ªªº°Ó«~¶}µo¤O¡F1966¦~¡]¬L©M41¦~¡^µo°âªº¼p©Ð¥Î¬~¾¯¡uÇÚÇÚÇèÇÞÇï¡v¦b¤é¥»´X¥G¬O¼p©Ð¥Î¬~¾¯ªº¥N¦Wµü¡C¡uÇåÇ~ÇÙÇïF¡v¹ê»Ú¤W¬O¥@¬É­º­Ó¼p©Ð¥Î¬~¾¯¡C



·à¤ý®è¦¡·|ªÀ
ÇåÇ~ǦÇï®è¦¡会ªÀ

¤½¥qÃþ«¬ªÑ²¼¥N¸¹¦¨¥ß³Ð¿ì¤H¥Nªí¤Hª«Á`³¡¼Ð»y¤f¸¹·~°È½d³ò²£«~Àç·~ÃBµ|«e¬Õ¾lµ|«á¬Õ¾lÁ`¸ê²£¸ê²£²b­È­û¤u¤H¼Æºô¯¸

¦ì©óªF¨Ê¥»©Òªº·à¤ýÁ`³¡¤j¼Ó
¤W¥«¤½¥q
ªFÃÒ1³¡¡G4912
¤é¥»ªF¨Ê¡]1918¦~9¤ë13¤é¡^
¤pªL´I¦¸­¦
¥Nªí¨ú½l§Ð·|ªø¡GÃí« ­s¼y
¥Nªí¨ú½l§ÐªÀªø¡GÀØ ¶h¤Ò
¤é¥» ¢E130-8644
ªF¨Ê³£¾¥¥Ð°Ï¥»©Ò¤@¤B¥Ø3µf7¸¹
Life. Love. LION.[1]
¥þ²y
®ø¶O©Ê²£«~¡B¤é¥Î«~
¡¶¥3311»õ¤é¶ê (2010¦~12¤ë)
¡¶¥105»õ¤é¶ê (2010¦~12¤ë)
¡¶¥60.41»õ¤é¶ê (2010¦~12¤ë)
¡¶¥2609.39»õ¤é¶ê (2010¦~12¤ë)
¡¶¥1057.6»õ¤é¶ê (2010¦~12¤ë)
5,972 (consolidated, (2010¦~12¤ë31¤é)
http://www.lion.co.jp/


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 15:46  ¸ê®Æ ¨p¤H°T®§ 
KOSÉ  °ªµ· (¤éªÑ 4922) (¤Æ§©«~)

https://www.kose.co.jp/jp/ja/index.html

https://zh.wikipedia.org/wiki/%E9%AB%98%E7%B5%B2


°ªµ·¡]¤é»y¡GǯÆãÇ·Æã¡F­^»y¡GKOSÉ¡^¡A¬O¤é¥»¤@®a¥H¤Æ§©«~»s³y»P³c°â¬°¥Dªº¥ø·~¡A¥Ñ³Ð¿ìªÌ¤pªL§µ¤T­¦µ²¦X¤Æ¾Ç»PÃľǤH¤h©ó1946¦~³Ð¥ß¡Cªì´Á¥H¥N²z¨ä¥L¬ü®e¤Æ§©«~µP¬°¥D¡A1948¦~¶}©lµo®i¦Û¤vªº«~µP¡C

®è¦¡·|ªÀ°ªµ·
®è¦¡会ªÀǯÆãÇ·Æã
¤½¥qÃþ«¬ªÑ²¼¥N¸¹¦¨¥ß³Ð¿ì¤H¥Nªí¤Hª«Á`³¡·~°È½d³ò²£·~²£«~­û¤u¤H¼Æ¹ê¦¬¸ê¥»ÃBºô¯¸
KOSÉ Corporation
¦ì©óªF¨Ê³£¤¤¥¡°Ïªº°ªµ·®è¦¡·|ªÀÁ`³¡
¤W¥«¤½¥q
ªFÃÒ1³¡¡G4922¡]2000¦~12¤ë4¤é¤W¥«¡^
1948¦~6¤ë11¤é
¤pªL§µ¤T­¦
¤pªL¤@«T¡]¥Nªí¨ú½l§ÐªÀªø¡^
¤é¥»
ªF¨Ê³£¤¤¥¡°Ï¤é¥»¾ô¤T¤B¥Ø6µf2¸¹
¤é¥»¡B­»´ä¡B¬ü°ê¡BÁú°ê¡B¥xÆW
¤Æ¾Ç¤u·~
¤ÆùÛ«~
³sµ²¡G5,079¦W ³æ¿W¡G2,081¤H
¡]2008¦~3¤ë¤î¡^
³sµ²¡G1,721»õ2,800¸U¤é¶ê
³æ¿W¡G1,185»õ500¸U¤é¶ê
¡]2008¦~3¤ë´Á¡^
http://www.kose.co.jp/


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 15:54  ¸ê®Æ ¨p¤H°T®§ 
³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 15:56  ¸ê®Æ ¨p¤H°T®§ 
POLA ORBIS HOLDINGS INC. (¤éªÑ 4927) (¤Æ§©«~)
  
https://zh.wikipedia.org/wiki/POLA

http://www.po-holdings.co.jp/index.html



®è¦¡·|ªÀPOLA¡]POLA Inc.¡^¡A¥D­n¨Æ·~¤º®e¬°¤k¥Î¤Æ§©«~/«O¾i«~ªº¥Í²£¤Î³c°â¡C
Á`¤½¥q¦ì©ó¤é¥»ªF¨Ê³£«~¤t°Ï¦è¤­¤Ï¥Ð2¤B¥Ø2µf3¸¹¡C
  
POLA ORBIS HOLDINGS INC.

­ì¤å¦WºÙ¤½¥qÃþ«¬ªÑ²¼¥N¸¹¦¨¥ß³Ð¿ì¤HÁ`³¡²£·~Àç·~ÃBÁ`¸ê²£¸ê²£²b­Èµ²ºâ´Á¥D­nªÑªF¥D­n¤l¤½¥qºô¯¸

POLA ORBIS HOLDINGS INC.
®è¦¡会ªÀÇÙÆãÇå・ǦÇçÇÏǵÇ×ÆãÇçÇÃÇ}ÇïǬǵ
¤W¥«¤½¥q
ªFµý1³¡ 4927
2006¦~¡]¥­¦¨18¦~¡^9¤ë29¤é
¹a¤ì郷¥v¡]¥Nªí¨ú½l§ÐªÀªø¡^
¤é¥»
¤Æ¾Ç
³sµ²2,184»õ82¦Ê¸U円
¡]2016¦~12¤ë´Á¡^
³sµ²2,288»õ45¦Ê¸U円
¡]2016¦~12¤ë¡^
³sµ²1,858»õ64¦Ê¸U円
¡]2016¦~12¤ë¡^
12/31
¤½¯q°]団ªk¤HPOLA¬ü³N®¶¿³°]団 34.31% ¹a¤ì郷¥v 22.18%
¡]2015¦~12¤ë¡^
POLA
®è¦¡·|ªÀÇÙÆãÇå・ǦÇçÇÏǵÇ×ÆãÇçÇÃÇ}ÇïǬǵ


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 16:01  ¸ê®Æ ¨p¤H°T®§ 
¤pªL»sÃÄ Kobayashi Pharmaceutical Company, Limited (¤éªÑ 4967)  (¤é¥Î«~,»sÃÄ)

https://www.kobayashi.co.jp/english/company/index.html

https://zh.wikipedia.org/wiki/%E5%B0%8F%E6%9E%97%E8%A3%BD%E8%97%A5


¤pªL»sÃĪѥ÷¦³­­¤½¥q¡A²ºÙ¤pªL»sÃÄ¡]­^»y¡GKobayashi Pharmaceutical Company, Limited¡A¤é»y¡G¤pªL»s薬®è¦¡会ªÀ¡AªFÃÒ1³¡¡G4967¡^¡A¦b1886¦~³Ð¥ß·í®É¦W¬°¡u¤pªL²±¤j°ó¡v¡A·í®ÉÁ`³¡¦ì©ó¦W¥j«Î¡A¦Ó³Ð¿ì¤H¬°¤pªL©¾§L½Ã¡A·í®É¸gÀç¥X°âÂø³f©±¡B¤Æ§©«~¤Î¬v°sµ¥¡C


²{®É¥D­n·~°È¨Æ·~(¦U¦¡¦U¼ËÂåÃÄ«~¡BªÚ­»¾¯¡B½Ã¥Í¥Î«~¡B¤é¥Î¥²»Ý«~¡B«O°·²£«~µ¥)¤Î¨ÑÀ³ÂåÀø¾÷¾¹ªº¾P°â¨Æ·~[1]¡A²{®ÉÁ`³¡¦ì©ó¤j¨Á©²¤j¨Á¥«¤¤¥¡°Ï¹D­×Ëm¥|¤B¥Ø4µf10¸¹KDX¤pªL¹D­×Ëm¤j¼Ó¡C¸³¨Æªø¤Î­º®u°õ¦æ©x¬°¤pªL¤@¶®¡C
¦ÓªÑ¥÷¦b1999¦~4¤ë20¤é©ó¤j¨ÁÃÒ¨é¥æ©ö©Ò¡]«á¤w¸Ñ´²¡^²Ä¤G³¡¤W¥«¡A¦Ó¦b2000¦~8¤ë22¤é©óªF¨ÊÃÒ¨é¥æ©ö©Ò©M¤j¨ÁÃÒ¨é¥æ©ö©Ò¡]«á¤w¸Ñ´²¡^²Ä¤@³¡¤W¥«¡C


2018¦~3¤ë29¤é¤pªL»sÃĤ½¥q¡A±N¦¬Áʤ@®a¤¤°êÂåÃÄ«~¥Í²£¾P°â¤½¥q¦¿Ä¬¤¤¤¦»sÃĦ³­­¤½¥q¡A¤µ«á±N¦b·í¦a¥Í²£©M¾P°â¦b¤¤°ê³X¤é¹C«È¤¤¤H®ð»á°ªªº®øª¢Âíµh¾¯¡u¦w¬üÅS¡vµ¥ÂåÃÄ«~¡C¦¬Áʪ÷ÃB¥¼¹ï¥~¤½¥¬


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 16:06  ¸ê®Æ ¨p¤H°T®§ 
Nifco (¤éªÑ 7988) ¶ì®Æ¦©¨ã


https://www.nifco.com/en/company/strengths.html




Nifco was founded in 1967 in order to manufacture and sell plastic fasteners for industrial purposes.


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 16:16  ¸ê®Æ ¨p¤H°T®§ 
Kyowa Hakko Kirin Co., Ltd. (¨ó©M発»ÃÇ©ÇæÇï®è¦¡会ªÀ) (¤éªÑ 4151) »sÃĥͪ«¬ì§Þ

http://www.kyowa-kirin.com/products/index.html


http://www.kyowa-kirin.com/about_us/overview/index.html



https://en.wikipedia.org/wiki/Kyowa_Hakko_Kirin

Kyowa Hakko Kirin Co., Ltd. (¨ó©M発»ÃÇ©ÇæÇï®è¦¡会ªÀ Kyōwa Hakkō Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.[4][5]


Kyowa Hakko Kirin Co., Ltd.


Type
Traded asIndustryFoundedHeadquartersKey people
ProductsRevenueNet income
Number of employees
ParentSubsidiariesWebsite
Public KK
TYO: 4151
FWB: KY4
Nikkei 225 Component

July 1, 1949
Ohtemachi Building, 1-6-1, Ōtemachi, Chiyoda-ku, Tokyo 100-8185, Japan
Nobuo Hanai, (CEO and President)

$ 3.548 billion USD (FY 2013)
(¥ 340.61 billion JPY) (FY 2013)
$ 31.32 million USD (FY 2013)
(¥ 30.07 billion JPY) (FY 2013)
7,532 (consolidated) (as of December 31, 2017)
Kirin Holdings Company, Limited
47 (33 in Japan and 14 overseas countries)
Official website
Footnotes / references
[1][2][3]


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 16:18  ¸ê®Æ ¨p¤H°T®§ 
¤j¤é¥»¦í¤Í»s薬®è¦¡会ªÀ  Sumitomo Dainippon Pharma Co., Ltd. (¤éªÑ 4506)  »sÃÄ

https://www.ds-pharma.co.jp/

https://zh.wikipedia.org/wiki/%E5%A4%A7%E6%97%A5%E6%9C%AC%E4%BD%8F%E5%8F%8B%E8%A3%BD%E8%97%A5


¤j¤é¥»¦í¤Í»sÃĪѥ÷¦³­­¤½¥q¡]¤é»y¡G¤j¤é¥»¦í¤Í»s薬®è¦¡会ªÀ¡B­^»y¡GSumitomo Dainippon Pharma Co., Ltd.¡^¬O¤é¥»¤@®a»sÃĤ½¥q¡C¨ä¬°¦í¤Í¤Æ¾Ç©ÒÄÝ¡C«e¨­¬°1897¦~¦¨¥ßªº¤j¨Á»s薬®è¦¡·|ªÀ»P1984¦~¦¨¥ßªº¦í¤Í»sÃĮ覡·|ªÀ¡C

¤j¤é¥»¦í¤Í»sÃĮ覡·|ªÀ


­ì¤å¦WºÙ¤½¥qÃþ«¬¦¨¥ß¥Nªí¤Hª«Á`³¡²£«~Àç·~ÃB­û¤u¤H¼Æ¹ê¦¬¸ê¥»ÃBµ²ºâ´Á¥D­nªÑªF¥D­n¤l¤½¥qºô¯¸

Sumitomo Dainippon Pharma Co., Ltd.
[/url]
¤j¤é¥»¦í¤Í»s薬®è¦¡会ªÀ
®è¦¡·|ªÀ
¤j¤é¥»»sÃÄ1897¦~5¤ë14¤é
¦í¤Í»sÃÄ1984¦~2¤ë6¤é
¦X¨Ö2005¦~10¤ë1¤é
¥Nªí¨ú½l§Ð·|ªø®cªZ°·¦¸­¦
¥Nªí¨ú½l§ÐªÀªø¦h¥Ð¥¿¥@
¤j¨Á©²¤j¨Á¥«¤¤¥¡°Ï¹D­×Ëm¤G¤B¥Ø6µf8¸¹
Âå薬«~¡BÁ{§ÉÀË査ÃÄ¡BÂåÀø¾÷¾¹¡B°Êª«¥ÎÂå薬«~
­¹«~²K¥[ª«¡B¤u·~薬«~¡B¨ä¥L¤Æ¾Ç»s«~ªº»s³y
3,0637.00»õ¤é¶ê¡]2010¦~¡A¥þÅéÀ禬¡^
7,407¦W¡]2010¦~3¤ë31¤é²{¦b¡^
224»õ円¡]2009¦~3¤ë¥½²{¦b¡^
¨C¦~3¤ë31¤é
¦í¤Í¤Æ¾Ç50.12%
稲畑産·~6.86%
¡]2010¦~3¤ë31¤é²{¦b¡^
DSP¤­¨óÇÑÆãÇÅ¡®Ç­ÇÛǧÇç®è¦¡·|ªÀ
http://www.ds-pharma.co.jp/


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 16:27  ¸ê®Æ ¨p¤H°T®§ 
KAKEN PHARMACEUTICAL CO.,LTD. (¤éªÑ 4521) »sÃÄ



http://www.kaken.co.jp/english/business/index.html


http://www.kaken.co.jp/english/about_kaken/profile.html



Kaken Pharmaceutical Co., Ltd. (KAKEN) is a specialty pharmaceutical company in Japan with strong experience in developing and commercializing novel pharmaceuticals and medical devices in the fields of orthopedics, dermatology and surgery.

The origins of KAKEN can be traced back to the Institute of Physical and Chemical Research (Riken), which was established in 1917. In 1948, Riken reorganized into Kagaku-Kenkyusho, which is the precursor of KAKEN, and started its pharmaceutical business by developing a new way to manufacture penicillin utilizing Riken¡¦ proprietary technologies.

KAKEN has since broadened the scope of its business activities to include the production and marketing of pharmaceuticals such as streptomycin, an anti-tuberculosis drug, and various antifungal agents. In recent years, KAKEN concentrates its R&D resources in inflammation/immunology (dermatitis, rheumatoid arthritis and osteoarthritis), pain relief and fungal infection areas.

KAKEN¡¦s ongoing quest is to bring smiles and happiness to as many people as possible. For this purpose, KAKEN strives to improve the quality of life of patients through the development and distribution of superior pharmaceuticals.


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 16:29  ¸ê®Æ ¨p¤H°T®§ 
Hisamitsu Pharmaceutical Co., Inc. ¤[¥ú»sÃĮ覡·|ªÀ (¤éªÑ 4530)  »sÃÄ

http://www.hisamitsu.co.jp/healthcare/


https://zh.wikipedia.org/wiki/%E4%B9%85%E5%85%89%E8%A3%BD%E8%97%A5

¤[¥ú»sÃĮ覡·|ªÀ¡]¤é»y¡G¤[¥ú»s薬®è¦¡会ªÀ¡B­^»y¡GHisamitsu Pharmaceutical Co., Inc.¡^¬O¤@®a¤é¥»ªº»sÃĤ½¥q¡AÁ`³¡¦ì©ó¦õ¶P¿¤³¾Ñᥫ¤ÎªF¨Ê³£¡C©ó1847¦~¡]¥°¤Æ4¦~¡^¦¨¥ßªº¸Ó¤½¥q¡A«e¨­­ì¦W¤pªQ«Î¡A¥H¥Í²£¨Ï¥Î¼»¶©¤Ú´µ¡]¤é»y¡GDZÇéÇïÇÍǵ¡A­^»y¡GSalonpas¡^§@¬°°Ó¼Ð¦Wªº»Äµh¶K¥¬»P¨ä­l¥ÍÃÄ«~¦Óª¾¦W¡C


¤[¥ú»sÃĦb¤E¦{Á`³¡©Ò¦bªº³¾Ñᥫ»P栃¤ì¿¤¦t³£®c¥«¦U³]¦³¤@®y¥Í²£¤u¼t¡A©ó¤é¥»°ê¤º¶±¥Î1,400¦W¥H¤Wªº­û¤u¡C

¤[¥ú»sÃĮ覡·|ªÀ
¤½¥qÃþ«¬¦¨¥ß¥Nªí¤Hª«Á`³¡²£·~Àç·~ÃB­û¤u¤H¼Æ¥D­n¤l¤½¥qºô¯¸
Hisamitsu Pharmaceutical Co., Inc.
¤W¥«¤½¥q
ªFÃÒ1³¡¡G4530
¦WÃÒ1³¡¡G4530
1847¦~
¤¤冨³Õ¶©¡]¦æ¬FÁ`µô¤ÎªÀªø¡^
¤é¥»¦õ¶P¿¤³¾Ñᥫ¥Ð¥N¤j©xËm408
»sÃÄ¡BÂåÀø½Ã¥Í
¡¶1,240»õ¤é¶ê¡]2009¦~2¤ë¡^
1,428¤H¡]2012¦~2¤ë¡^
Hisamitsu America Inc.
Noven Pharmaceuticals, Inc.
Hisamitsu Farmaceutica do Brasil Ltda.
¤[¥ú»sÃħ޳N¿Ô¸ß¡]¥_¨Ê¡^¦³­­¤½¥q
Hisamitsu Vietnam Pharmaceutical Co., Ltd.
PT.Hisamitsu Pharma Indonesia
Hisamitsu UK Limited
www.hisamitsu.co.jp


³»³¡
kaka
¦P¾Ç




UID 6717
ºëµØ 0
¿n¤À 0
©«¤l 6266
¾\ŪÅv­­ 99
µù¥U 2014-5-7
¥Î¤áµù¥U¤Ñ¼Æ 3644
¥Î¤á¥¢ÂÜ¤Ñ¼Æ 1750

220.133.160.84
µoªí©ó 2018-10-13 16:34  ¸ê®Æ ¨p¤H°T®§ 
TSUMURA & CO. (¤éªÑ 4540) »sÃÄ (º~¤è»s¾¯,ÂåÀø«~)

http://www.tsumura.co.jp/

http://www.tsumura.co.jp/english/kampo/


³»³¡